A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) ...
April 26, 2011 — The US Food and Drug Administration has approved lamotrigine extended release for conversion to monotherapy for partial seizures. This is a new indication for the GlaxoSmithKline ...
The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, mexiletine and lamotrigine, on people with the condition. The trial, which ...
Two common antiseizure medications, lamotrigine and levetiracetam, are safe to use during pregnancy, according to a Stanford Medicine-led study. The research, which was published online Nov. 25 in ...
Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and ...
Findings published by The BMJ today reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results